BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  Sanofi Forges Second Partnership to Develop COVID-19 Vaccine

  Sanofi Pasteur and Translate Bio have partnered to develop a novel messenger RNA vaccine for COVID-19, the disease caused by the novel coronavirus.

  March 27, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  BMS, Merck and Pfizer Join List of Companies Pausing Some Clinical Trials During Pandemic

  As COVID-19 continues to expand across the globe, more pharmaceutical companies are hitting the brakes on clinical trials as part of an effort to ease the burden on doctors and facilities needed to treat patients combating the disease.

  March 27, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Clinical Catch-Up: March 23-27

  Although some clinical trials are being slowed or halted, others are reporting out data. Here’s a look.

  March 27, 2020

   · 

  8 min read

   · 

  Mark Terry
• 

  Business

  Biotech Calls for More Collaboration and Communication During COVID-19 Pandemic

  One of the key takeaways from BIO-Europe Spring 2020 was that there is a keen need for greater collaboration and communications among the biotech community, government, non-governmental organizations and the public.

  March 27, 2020

   · 

  4 min read

   · 

  Gail Dutton
• 

  Business

  Evox and Takeda Partner for Multi-Target Collaboration in Rare Diseases

  The two companies plan to focus their efforts on targeting several rare diseases.

  March 27, 2020

   · 

  2 min read

   · 

  Michelle Brugioni
• 

  Policy

  Genentech’s Xofluza Submitted to FDA for New Children’s Formulations

  The NDA is for a new formulation of the drug as one-dose granules for oral suspension, would which largely be aimed at children and people who have difficulty swallowing.

  March 27, 2020

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  With Pivots and Clinical Holds, Troubled Unum Considering its Strategic Options

  Troubled Unum Therapeutics announced its fourth quarter and full-year financial report yesterday. Among the news was that it is considering seemingly every possible strategic option, including a sale or merger.

  March 27, 2020

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Medimetriks and Otsuka’s Difamilast Hits Mark in Atopic Dermatitis Trials

  Difamilast is a novel atopic dermatitis compound discovered by Otsuka.

  March 27, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  FDA Action Alert: Bristol Myers Squibb, Acceleron and UroGen

  Here’s a look at the next two target action dates on the calendar for early April.

  March 27, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Biopharma Industry News for March 27: Update on the Novel Coronavirus

  A summary of daily biopharma industry news. Please check out stories that are trending on March 27, 2020.

  March 27, 2020

   · 

  3 min read

   · 

  BioSpace Editorial Staff